Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hood

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|March 29, 2012
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patientClaire Cordina, Robert Hill, Ashutosh Deshpande, et al.
Kidney International Reports|January 11, 2018
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic NephropathyAjith Munasinghe Dissanayake, Mark Christopher Wheldon, Jafar Ahmed, et al.
Lancet (London, England)|April 20, 2010
Anthrax infection in drug usersMalcolm G Booth, John Hood, Timothy J G Brooks, et al.
Chaos (Woodbury, N.Y.)|April 30, 2022
Model-assisted deep learning of rare extreme events from partial observationsAnna Asch, Ethan J Brady, Hugo Gallardo, et al.
The Journal of Biological Chemistry|April 17, 2002
Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetaseKeisuke Wakasugi, Bonnie M Slike, John Hood, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 16, 2020
A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690), as a potential disease-modifying agent for the treatment of degenerative disc diseaseVishal Deshmukh, Maureen Ibanez, Haide Hu, et al.
Journal of Immunological Methods|November 10, 2009
Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412Lucy Findlay, David Eastwood, Richard Stebbings, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as TotalJohn Hood, Ignacio González-García, Nicholas White, et al.
Circulation Research|April 6, 2002
A dominant-negative p65 PAK peptide inhibits angiogenesisWilliam B Kiosses, John Hood, Suya Yang, et al.
Journal of Medical Microbiology|November 27, 2002
Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug usersChristopher C McGUIGAN, Gillian M Penrice, Laurence Gruer, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|March 29, 2012
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patientClaire Cordina, Robert Hill, Ashutosh Deshpande, et al.
Kidney International Reports|January 11, 2018
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic NephropathyAjith Munasinghe Dissanayake, Mark Christopher Wheldon, Jafar Ahmed, et al.
Lancet (London, England)|April 20, 2010
Anthrax infection in drug usersMalcolm G Booth, John Hood, Timothy J G Brooks, et al.
Chaos (Woodbury, N.Y.)|April 30, 2022
Model-assisted deep learning of rare extreme events from partial observationsAnna Asch, Ethan J Brady, Hugo Gallardo, et al.
The Journal of Biological Chemistry|April 17, 2002
Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetaseKeisuke Wakasugi, Bonnie M Slike, John Hood, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 16, 2020
A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690), as a potential disease-modifying agent for the treatment of degenerative disc diseaseVishal Deshmukh, Maureen Ibanez, Haide Hu, et al.
Journal of Immunological Methods|November 10, 2009
Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412Lucy Findlay, David Eastwood, Richard Stebbings, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as TotalJohn Hood, Ignacio González-García, Nicholas White, et al.
Circulation Research|April 6, 2002
A dominant-negative p65 PAK peptide inhibits angiogenesisWilliam B Kiosses, John Hood, Suya Yang, et al.
Journal of Medical Microbiology|November 27, 2002
Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug usersChristopher C McGUIGAN, Gillian M Penrice, Laurence Gruer, et al.
Pageof 5